Earnings Call · Q4 FY2024·2025-02-13

Q4 24EPS -2.44%·Rev n/aQ3 24EPS +10.26%·Rev n/aQ2 24EPS +13.51%·Rev n/aQ1 24EPS +5.88%·Rev n/a⚠ consensus missing

IRADIMED CORP IRMD

Roger Susi — Chief Executive Officer

John Glenn — Chief Financial Officer

−2.8%1d on move date−1.3% vs SPY3d−1.2%5d+0.3%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IRMD calls or request research access.

More IRMD calls Browse calls Request research access